STIM Glenn P Muir buys $680K worth of shares
Jan 03, 2026, 5:41 AM
0.00%
What does STIM do
Neuronetics, based in Malvern, Pennsylvania, develops the NeuroStar Advanced Therapy System, a TMS device for treating major depressive disorder. The company went public on June 28, 2018, and employs 202 people.
Glenn P Muir bought 40,000 shares of STIM on 2 July at $17.00 per share, worth a total of $680K. They now own 40,000 STIM shares.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.